Rhythm Pharmaceuticals Inc (RYTM) Insider Trading
- $22,046,700.00
- $58,104,005.31
- March 21, 2025
- Todd Foley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 21, 2025 | CAO | 344 | $54.23 | Sell | $18,655.12 | |
March 14, 2025 | EVP | 75,000 | $51.48 | Sell | $3,861,000.00 | |
Feb. 19, 2025 | CAO | 635 | $57.22 | Sell | $36,334.70 | |
Feb. 19, 2025 | CFO | 2,215 | $57.22 | Sell | $126,742.30 | |
Feb. 19, 2025 | CEO | 9,896 | $57.22 | Sell | $566,249.12 | |
Feb. 19, 2025 | Insider | 1,228 | $57.22 | Sell | $70,266.16 | |
Feb. 19, 2025 | EVP | 2,035 | $57.22 | Sell | $116,442.70 | |
Feb. 12, 2025 | EVP | 1,815 | $56.39 | Sell | $102,347.85 | |
Feb. 11, 2025 | CFO | 1,296 | $57.51 | Sell | $74,532.96 | |
Feb. 11, 2025 | Insider | 794 | $57.51 | Sell | $45,662.94 | |
Feb. 10, 2025 | EVP | 4,189 | $58.91 | Sell | $246,773.99 | |
Feb. 4, 2025 | Insider | 1,281 | $59.43 | Sell | $76,129.83 | |
Feb. 4, 2025 | EVP | 1,447 | $59.43 | Sell | $85,995.21 | |
Feb. 4, 2025 | CEO | 4,278 | $59.43 | Sell | $254,241.54 | |
Feb. 4, 2025 | CFO | 1,678 | $59.43 | Sell | $99,723.54 | |
Nov. 11, 2024 | EVP | 66,861 | $66.33 | Sell | $4,434,890.13 | |
Nov. 11, 2024 | insider | 13,281 | $66.44 | Sell | $882,389.64 | |
Nov. 7, 2024 | Insider | 4,688 | $65.00 | Sell | $304,720.00 | |
Sept. 17, 2024 | Director | 31,751 | $52.40 | Sell | $1,663,752.40 | |
Sept. 10, 2024 | Director | 17,501 | $49.65 | Sell | $868,924.65 | |
Sept. 9, 2024 | Insider | 4,099 | $50.03 | Sell | $205,072.97 | |
Aug. 26, 2024 | Insider | 3,200 | $50.01 | Sell | $160,032.00 | |
Aug. 26, 2024 | Director | 4,300 | $50.01 | Sell | $215,043.00 | |
Aug. 9, 2024 | Insider | 49,006 | $45.15 | Sell | $2,212,620.90 | |
July 29, 2024 | Insider | 1,395 | $49.06 | Sell | $68,438.70 | |
July 16, 2024 | Insider | 10,468 | $53.00 | Sell | $554,804.00 | |
July 12, 2024 | Insider | 5,313 | $50.01 | Sell | $265,703.13 | |
May 9, 2024 | Insider | 3,984 | $38.47 | Sell | $153,264.48 | |
April 2, 2024 | CAO | 368 | $41.76 | Sell | $15,367.68 | |
March 21, 2024 | Insider | 18,235 | $40.34 | Sell | $735,599.90 | |
March 19, 2024 | EVP | 16,000 | $39.22 | Sell | $627,520.00 | |
March 19, 2024 | CFO | 15,515 | $39.22 | Sell | $608,498.30 | |
March 19, 2024 | CEO | 45,494 | $39.22 | Sell | $1,784,274.68 | |
Feb. 14, 2024 | Insider | 1,089 | $50.01 | Sell | $54,460.89 | |
Feb. 12, 2024 | EVP | 1,594 | $51.38 | Sell | $81,899.72 | |
Feb. 12, 2024 | Insider | 791 | $51.38 | Sell | $40,641.58 | |
Feb. 12, 2024 | CFO | 1,209 | $51.38 | Sell | $62,118.42 | |
Feb. 9, 2024 | Insider | 71,774 | $50.38 | Sell | $3,615,974.12 | |
Dec. 27, 2023 | Insider | 5,015 | $50.01 | Sell | $250,800.15 | |
Dec. 5, 2023 | CFO | 7,026 | $35.06 | Sell | $246,331.56 | |
Nov. 24, 2023 | CFO | 10,974 | $35.02 | Sell | $384,309.48 | |
Nov. 8, 2023 | EVP | 5,712 | $28.90 | Sell | $165,076.80 | |
Nov. 3, 2023 | EVP | 80 | $28.00 | Sell | $2,240.00 | |
Sept. 5, 2023 | EVP | 6,166 | $28.05 | Sell | $172,956.30 | |
Aug. 9, 2023 | EVP | 1,718 | $24.66 | Sell | $42,365.88 | |
Aug. 7, 2023 | EVP | 11,223 | $24.18 | Sell | $271,372.14 | |
July 26, 2023 | Insider | 930 | $17.64 | Sell | $16,405.20 | |
March 29, 2023 | CAO | 912 | $17.50 | Sell | $15,960.00 | |
Feb. 14, 2023 | Insider | 554 | $26.87 | Sell | $14,885.98 | |
Feb. 14, 2023 | EVP | 635 | $26.87 | Sell | $17,062.45 |
Insiders are both buying and selling Rhythm Pharmaceuticals Inc stock.
The insider traders at Rhythm Pharmaceuticals Inc are: Todd Foley, Joseph Shulman, Hunter C Smith, Jennifer Kayden Lee, Pamela J Cramer, Keith Michael Gottesdiener, Der Ploeg Leonardus H.T. Van, David P Meeker, Yann Mazabraud, Ra Capital Management, L.P., Christopher Paul German, William T Roberts, Lynn A Tetrault, Nithya Desikan, Jennifer Chien, Jennifer L Good, Orbimed Advisors Llc, James E Flynn, Bros. Advisors Lp Baker, and S.A. Ipsen
The most active insider trader at Rhythm Pharmaceuticals Inc is Todd Foley with 24 trades.
Todd Foley has sold the most Rhythm Pharmaceuticals Inc stock with a total value of $16,758,186.66.
Bros. Advisors Lp Baker has bought the most Rhythm Pharmaceuticals Inc stock with a total value of $30,090,000.00.
The most recent insider trade for Rhythm Pharmaceuticals Inc was on March 21, 2025.
The single biggest insider buy for Rhythm Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $15,045,000.00 on Oct. 5, 2017.
The single biggest insider sell for Rhythm Pharmaceuticals Inc was from Jennifer Kayden Lee with a total value of $4,434,890.13 on Nov. 11, 2024.